Retail investors drive demand for Gem Aromatics IPO; subscription nears 2x

The unlisted shares of Gem Aromatics continue to command a decent premium in the grey market on the second day of its subscription

Gem Aromatics IPO
Gem Aromatics IPO is being offered at a price band of ₹309-325 per share, with a lot size of 46 shares.
Kumar Gaurav New Delhi
4 min read Last Updated : Aug 20 2025 | 12:56 PM IST
Gem Aromatics IPO subscription status: Retail investors are leading the demand for the initial public offering (IPO) of specialty ingredients manufacturer Gem Aromatics (Gem Aromatics IPO) on the second day of its subscription, Wednesday, August 20, 2025. This is closely followed by non-institutional investors (NIIs), and qualified institutional buyers (QIBs).
 
According to BSE data, the Gem Aromatics IPO has been oversubscribed by 1.78 times by 12:42 PM on Wednesday. Among the individual categories, retail investors and NIIs have oversubscribed the categories reserved for them by 2.05 times and 1.93 times, respectively. QIBs, on the other hand, have oversubscribed the category reserved for them by 1.18 times.

Gem Aromatics IPO details

Gem Aromatics seeks to raise ₹451.25 crore from the public offering, which comprises an entirely fresh issue of 5.4 million equity shares worth ₹175 crore, and an offer for sale (OFS) of 8.5 million equity shares, aggregating up to ₹276.25 crore.
 
Gem Aromatics IPO is being offered at a price band of ₹309-325 per share, with a lot size of 46 shares. To bid for a minimum of one lot or 46 shares of the Gem Aromatics IPO, a retail investor would need a minimum of ₹14,950 (considering the upper price band). A retail investor can bid for a maximum of 13 lots or 598 shares of Gem Aromatics with an investment amount of ₹1,94,350.  ALSO READ: Mangal Electrical IPO opens today: GMP up 4%; should you park your money?

Gem Aromatics IPO grey market premium (GMP) today

The unlisted shares of Gem Aromatics continue to command a decent premium in the grey market on the second day of its subscription.
 
Sources tracking unofficial market activities revealed that Gem Aromatics shares were trading at around ₹351 per share, reflecting a grey market premium (GMP) of ₹26 or 8 per cent over the upper end of the issue price.

Gem Aromatics IPO review

The company has received favorable reviews from brokerages for its public offering. Analysts at Swastika Investmart have suggested that investors subscribe to the Gem Aromatics IPO, while those at Anand Rathi Research have recommended bidding for the issue from a long-term perspective. READ MORE

Gem Aromatics IPO allotment date, listing date

The three-day subscription window to bid for the public issue is set to close on Thursday, August 21, 2025. Following that, the basis of allotment of Gem Aromatics IPO shares is likely to be finalised on Friday, August 22, 2025. The successful allottees will receive the company’s shares in their demat accounts tentatively by Monday, August 25.
 
Shares of Gem Aromatics are scheduled to list on BSE SME, tentatively on Tuesday, August 26, 2025.

Gem Aromatics IPO registrar, lead manager

For the public offering of Gem Aromatics, KFin Technologies serves as the registrar, while Motilal Oswal Investment Advisors is the sole book-running lead manager.

Gem Aromatics IPO objective

According to the Red Herring Prospectus (RHP), Gem Aromatics will not receive any proceeds from the OFS. The proceeds will be allocated to each of the selling shareholders, after deducting the offer-related expenses and relevant taxes.
 
Gem Aromatics, however, proposes to utilise the proceeds from the fresh issue for the prepayment and/or repayment, in full or in part, of certain outstanding borrowings availed by the company and its subsidiary, Krystal Ingredients. The company will further deploy the proceeds for general corporate purposes.

About Gem Aromatics

Gem Aromatics is a manufacturer of specialty ingredients, including essential oils, aroma chemicals, and value-added derivatives in India, with a track record of over two decades. The company offers a diversified portfolio of products, ranging from Mother Ingredients to various Value-Added Derivatives. Its products find applications across a broad spectrum of industries, such as oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness and pain management, and personal care.
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :IPO GMPIPO allotmentIPOsinitial public offerings IPOsIPO marketIPO REVIEWIPO listing time

First Published: Aug 20 2025 | 12:56 PM IST

Next Story